Neurofibromatosis Research Helping Scientists to Understand Autism
People with neurofibromatosis type 1 have a higher incidence of many different complications. Tumor growth and learning disabilities are especially…
Read MorePeople with neurofibromatosis type 1 have a higher incidence of many different complications. Tumor growth and learning disabilities are especially…
Read MoreAt NF Midwest’s annual symposium in October 2014 we invited Eva Dombi, MD, from the National Cancer Institute to present…
Read MoreDr. Maria Acosta at Children’s National Medical Center is looking for parents of children with Neurofibromatosis Type 1 in which…
Read MoreNF Midwest has previously funded studies by Dr. Klein-Tasman’s team that has resulted in valuable information on the cognitive abilities…
Read MoreWe are conducting an important survey of patients with NF1 about electrosurgical removal of neurofibromas (dermal (cutaneous)) and/or subcutaneous tumors…
Read MoreCollaborators from the University of Wisconsin – Dept. of Psychology have published a THIRD paper based on cognitive studies of…
Read MoreWe are proud to learn that Christy Casnar, a collaborator on an ongoing study that NF Midwest has funded for…
Read MoreIt can be challenging to gather information from enough people for neurofibromatosis type 1 research. Having a large number of…
Read MoreMembers of NF Midwest, NF Northeast and Texas NF visited Cold Spring Harbor laboratory in New York in the…
Read MoreWe are excited and proud to announce our collaboration with the University of Wisconsin-Madison, Biotechnology Center. The UW Biotechnology Center…
Read More
© 2024 Neurofibromatosis Midwest - non profit 501(c)(t3). Site Map - Privacy Policy
The resources on this site should not be used as a substitute for professional medical care or advice on Neurofibromatosis. Users seeking information about a personal genetic disease, syndrome, or condition should consult with a qualified healthcare professional.